Progress and Challenges in Baltimore, Biopharmaceutical Updates, and Healthcare Innovations

Baltimore's federal delegation, led by Mayor Brandon Scott, highlighted improvements in crime rates and overdose deaths while emphasizing the threat of federal actions on progress. Soligenix Inc. and Izotropic Corporation are advancing in rare disease treatments and breast cancer imaging, respectively. Lantern Pharma introduces an AI module for oncology drug development, while Kairos Pharma reports positive results in a prostate cancer drug study. Intelligent Bio Solutions expands its non-invasive drug testing portfolio, and HealthLynked Corp. engages Meridian Group to drive strategic partnerships and Nasdaq uplisting goals.